DRDx to Drdx Home


Drug Response Dx GmbH – Our Mission


The health care system is – at present and in the future – facing rising requirements with regard to the effectiveness of medications and therapies. Challenge and necessity of personalized medicine and individualized therapies demand for convincing and reliable companion diagnostics. In the future, no treatment will be applied, if appropriate diagnostics have not predicted the outcome in advance:

DRDx makes drug response predictable


News – Press – Events


January 7, 2013

Drug Response Dx attracts first investment


The Hennigsdorf firm Drug Response Dx GmbH (DRDx GmbH) successfully concluded its first round of financing with High-Tech Gründerfonds and QIAGEN. The investment will serve to develop a biomarker test kit for rheumatoid arthritis treatment guidance with so-called TNF-alpha inhibitors. The test is secured by a unique patent platform exclusively in-licensed by the Max Planck Society.

more